# Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors

> **NCT01111097** · PHASE1 · COMPLETED · sponsor: **University of Florida** · enrollment: 15 (actual)

## Conditions studied

- Brain Tumor
- Glioblastoma

## Interventions

- **DRUG:** Dichloroacetate

## Key facts

- **NCT ID:** NCT01111097
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2015-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01111097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01111097, "Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01111097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*